F-group (family)
312.1.1.2 HIT
Ligands and drugs
488
Member domains
217
with ligand contacts (≤ 4 Å)
44.5% of members
230
with DrugDomain annotations
47.1% of members
149
with a DrugBank compound
30.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 312.1.1.2 belongs to X-group 312 HIT-like, which binds 6.8 ligand superclasses per 20 proteins, narrower than 63% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00131 | AMP | Adenosine phosphate | 34 |
| DB01972 | 5GP | Guanosine-5'-Monophosphate | 18 |
| DB00640 | ADN | Adenosine | 9 |
| DB04457 | DGP | 2'-Deoxyguanosine-5'-Monophosphate | 4 |
| DB04566 | IMP | Inosinic Acid | 4 |
| DB00127 | SPM | Spermine | 3 |
| DB03148 | AP2 | Adenosine 5'-methylenediphosphate | 3 |
| DB00369 | L8P | Cidofovir | 2 |
| DB01717 | AP5 | Bis(Adenosine)-5'-Pentaphosphate | 2 |
| DB02162 | 5AS | 5'-O-(N-Ethyl-Sulfamoyl)Adenosine | 2 |
| DB02183 | ADW | Adenosine-5'-ditungstate | 2 |
| DB02857 | GMP | Guanosine | 2 |
| DB03349 | 8BR | 8-Bromo-Adenosine-5'-Monophosphate | 2 |
| DB03376 | A5A | 5'-O-(N-(Alanyl)sulfamoyl)adenosine | 2 |
| DB03403 | C5P | Cytidine-5'-Monophosphate | 2 |
| DB03635 | ESA | Ethanesulfonic acid | 2 |
| DB03685 | U5P | Uridine monophosphate | 2 |
| DB04389 | IB2 | Ado-P-Ch2-P-Ps-Ado | 2 |
| DB14636 | TR5 | Triciribine phosphate | 2 |
| DB16833 | ADP | Adenosine disphosphate | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| AMP | ADENOSINE MONOPHOSPHATE | 27 |
| ZNmetal | ZINC ION | 26 |
| CL | CHLORIDE ION | 24 |
| 5GP | GUANOSINE-5'-MONOPHOSPHATE | 16 |
| NAmetal | SODIUM ION | 13 |
| ADN | ADENOSINE | 6 |
| 6BI | [(2~{R},3~{S},4~{R},5~{R})-5-[6-(ethylamino)purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate | 4 |
| UNL | Unknown ligand | 4 |
| B4P | BIS(ADENOSINE)-5'-TETRAPHOSPHATE | 3 |
| DGP | 2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE | 3 |
| FRU | beta-D-fructofuranose | 3 |
| SPM | SPERMINE | 3 |
| 67D | 3-(5-O-{[3-(1H-indol-3-yl)propanoyl]sulfamoyl}-beta-D-ribofuranosyl)-3H-imidazo[2,1-i]purine | 2 |
| 6CE | 5'-S-[(S)-hydroxy{[2-(1H-indol-3-yl)ethyl]amino}phosphoryl]-5'-thioguanosine | 2 |
| 6CG | 5'-S-phosphono-5'-thioguanosine | 2 |
| 6UR | [(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-~{N}-[2-(1~{H}-indol-3-yl)ethyl]phosphonamidic acid | 2 |
| 6UT | [(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-~{N}-[(2~{S})-3-(1~{H}-indol-3-yl)-1-(methylamino)-1-oxidanylidene-propan-2-yl]phosphonamidic acid | 2 |
| 777 | [(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-3~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-~{N}-ethyl-phosphonamidic acid | 2 |
| 9ZA | [(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-~{N}-[(2~{S})-1-methoxy-1-oxidanylidene-propan-2-yl]phosphonamidic acid | 2 |
| 9ZD | [(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-~{N}-[(2~{R})-1-methoxy-1-oxidanylidene-propan-2-yl]phosphonamidic acid | 2 |